Contributions
269 recent contributions in Hansard
HANSARD OrkambiLast week, one of my constituents, whose daughter suffers from cystic fibrosis, came to see me. He explained that every year that access to Orkambi or other such similar drugs is…04 Feb 2019HANSARD OrkambiI am not quite sure I follow. I would have been much more sympathetic to Vertex if it had not been doing share buybacks. If a company expects to make $13 billion of profit, it…04 Feb 2019HANSARD OrkambiI am sure that the hon. Gentleman’s constituents will be grateful to him for raising the issue in the House this evening. Every week, five babies are born with the disease,…04 Feb 2019HANSARD OrkambiI suggest that the hon. Gentleman hears the rest of the speech before he expects to draw any conclusions. Cystic fibrosis is a life-limiting genetic disorder. Patients with cystic…04 Feb 2019HANSARD OrkambiNo, I do not agree. The purpose of this debate is to a show an alternative that allows NICE to spend taxpayers’ money on drugs for other conditions while still allowing cystic…04 Feb 2019HANSARD OrkambiFirst, let me say how sorry I am to hear about the hon. Lady’s niece. We should take this very seriously. The figures that I have are even worse than the ones that she has laid…04 Feb 2019HANSARD OrkambiI tragically allowed the hon. Gentleman’s intervention one sentence too early. I was about to say that Crown use licensing would make the drug available to cystic fibrosis…04 Feb 2019HANSARD OrkambiI have. This drug would cost £104,000 if bought from Vertex and about £5,000 if it were made generically, so there is a huge saving.04 Feb 2019HANSARD Leaving the EUI have sat through the entirety of the exchanges on this statement, and those on many before it, and I commend the Prime Minister for keeping her temper and for the polite way in…14 Jan 2019